SCHEMBL12948874

SCHEMBL12948874

Cc1nc(-c2cccc(Cl)c2)c(C)n1-c1ccn(CCO)c(=O)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 4/20 0.37
CYP1A2 P05177 5/20 0.36
CYP2C9 P11712 4/20 0.36
CYP2C19 P33261 3/20 0.36
CYP2D6 P10635 1/20 0.36
TSHR P16473 3/20 0.36
CYP3A4 P08684 3/20 0.36
HSD17B10 Q99714 2/20 0.36
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
HPD P32754 1/20 0.36
RXRA P19793 1/20 0.35
RXRB P28702 1/20 0.35
RXRG P48443 1/20 0.35
USP2 O75604 2/20 0.35
MAPK1 P28482 1/20 0.35
HIF1A Q16665 1/20 0.35
MAOB P27338 1/20 0.35
CACNA2D1 P54289 1/20 0.35
KMT2A Q03164 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12948813 0.89 ALDH1A1 (0.40) TSHRHSD17B10ALDH1A1KDM4EHPD
SCHEMBL12948829 0.88 CYP1A2 (0.42) MDM2CYP1A2CYP2C9CYP2C19CYP2D6
SCHEMBL12948896 0.88 CYP1A2 (0.43) CYP1A2CYP2C9CYP2C19CYP2D6TSHR
SCHEMBL12948807 0.85 GRM5 (0.41) MDM2CYP1A2CYP2C9CYP2C19CYP2D6
SCHEMBL12948831 0.84 GRM5 (0.36)
SCHEMBL979792 0.80 GRM5 (0.40) CYP1A2CYP2C9CYP2C19CYP2D6HPD
SCHEMBL12948821 0.79 TLR8 (0.40) MAOBKMT2AMEN1NPC1RAB9A
SCHEMBL12948704 0.77 GLO1 (0.36) CYP1A2CYP2C19TSHRCYP3A4HSD17B10
SCHEMBL12948876 0.77 CYP1A2 (0.40) MDM2CYP1A2CYP2C9CYP2C19CYP2D6
SCHEMBL12948897 0.77 DCTPP1 (0.37) TSHRALDH1A1KDM4ERXRARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8334287-B2 Imidazoles HOFFMANN-LA ROCHE INC. (US) 2012-12-18 US disclosed
US-20110015202-A1 IMIDAZOLES F. HOFFMANN-LA ROCHE AG (CH) 2011-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110015202-A1 IMIDAZOLES GRM5, GRM1, GRIK5 MDM2 4032/4885CYP1A2 1068/4885CYP2C9 1167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.